Floatz logo

Vinorelbine Ditartrate

HER2 Positive Breast Carcinoma

Fudan UniversitySmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
65/ 100

Competitive context

175 Active assets in the HER2 Positive Breast Carcinoma cohort.

Asset / SponsorPhaseRating
Pertuzumab
SWOG Cancer Research Network
Phase 4BB
TRASTUZUMAB
SWOG Cancer Research Network
Phase 4BB
Ribociclib
Danish Breast Cancer Cooperative Group
Phase 3BB
Docetaxel
Ohio State University Comprehensive Cancer Center
Phase 3BB
Capecitabine
MedSIR
Phase 4BB

View all 50 →

Same molecule, other indications

Vinorelbine Ditartrate is also rated in:

Hodgkins lymphomaActive
BBB
Indicative · Phase 3
72 / 100
View asset →
cervical cancerDormant
BBB
Indicative · Phase 2
72 / 100
View asset →
non-small cell lung carcinomaActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →